Journals / Türk Jinekoloji ve Obstetrik Derneği Dergisi / 2014 / Cilt: 11 - Sayı: 2

The evaluation of perinatal outcomes in pregnancies complicated with thrombophilias

Trombofili saptanan gebelerde perinatal sonuçlarının değerlendirilmesi

Pages
88–93
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Differences between both groups were statistically significant at a p value

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In our study we included pregnant patients diagnosed with thrombophilia in whom thromboprophylaxis was initiated and evaluated their perinatal outcomes (pregnancy loss, preeclampsia, low birth weight, preterm labor, and venous thrombosis).
📊
Key Findings & Data:Material and Methods: Pregnant subjects that applied to Obstetrics and Gynecology Department of Çukurova University Faculty of Medicine Hospital between June 2010 and February 2012 were recruited in the study.
💡
Conclusion & Impact:Differences between both groups were statistically significant at a p value
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In our study we included pregnant patients diagnosed with thrombophilia in whom thromboprophylaxis was initiated and evaluated their perinatal outcomes (pregnancy loss, preeclampsia, low birth weight, preterm labor, and venous thrombosis). We aimed to compare perinatal outcomes of the study group with those of control group with negative thrombophilia screening results. Material and Methods: Pregnant subjects that applied to Obstetrics and Gynecology Department of Çukurova University Faculty of Medicine Hospital between June 2010 and February 2012 were recruited in the study. Patients with a positive thrombophilia screening for primary and secondary recurrent pregnancy loss were initiated a thromboprophylaxia protocol in the first trimester and their demographic backgrounds and past obstetric histories were also recorded. In addition to this, the type of thrombophilia and number of thrombophilia defects were also noted and the route of birth and perinatal outcomes were evaluated prospectively. The control group included patients who had a history of recurrent unexplained miscarriages, with a negative thrombophilia screening. Differences between both groups were statistically significant at a p value

Özet

Amaç: Çalışmamızda trombofili saptanıp gebe olarak başvuran ve tromboprofilaksi başlanan hastaların perinatal sonuçlarını (gebelik kaybı, preeklampsi, düşük doğum ağırlıklı (DDA), preterm doğum, venöz tromboz) değerlendirmeyi ve aynı dönemde trombofili taraması negatif olan hastalardaki perinatal sonuçlar ile karşılaştırmayı amaçladık. Gereç ve Yöntemler: Araştırmamızda Çukurova Üniversitesi Tıp Fakültesi, Kadın Hastalıkları ve Doğum Anabilim Dalı, Gebe Polikliniğinde Haziran 2010 ile Şubat 2012 tarihleri arasında gebelik takibi yapılan hastalar yer aldı. Daha önce primer ve sekonder tekrarlayan gebelik kaybı nedeni ile düşük araştırması yapılmış olup, etyolojik nedenlerden sadece trombofili testlerinden en az biri pozitif çıkan hastalar çalışmaya dahil edildi. Bu hastalara gebeliğin ilk trimesterinde tromboprofilaksi başlandı ve hastaların demografik özellikleri, önceki gebelik öyküsü, trombofili tipi ve trombofilik defekt sayısı kaydedildi. Doğum şekilleri ve perinatal sonuçları prospektif olarak incelendi. Araştırmamızın kontrol grubu tekrarlayan gebelik kaybı nedeni ile düşük araştırılması yapılmış olan ve trombofili taraması negatif olan gebelerden oluşturuldu. Sonuçlar arasında istatistiksel önem düzeyi için p değeri

🔖

Cite This Article

MELEKOĞLU, R., DEMİR, C., KAFADAR, Y. T., ÖZGÜNEN, F. T., EVRÜKE, C. (2022). The evaluation of perinatal outcomes in pregnancies complicated with thrombophilias. Türk Jinekoloji ve Obstetrik Derneği Dergisi, Cilt: 11 - Sayı: 2, 88–93. https://ajindex.com/articles/631491

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Pabinger I. Thrombophilia and its impact on pregnancy. Thromb Res 2009;123 Suppl 3:S16-21
  2. Sood R. Thrombophilia and fetal loss: Lessons from gene targeting in mice. Thromb Res 2009;123 (Suppl. 2):S79-84 3. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009;36(2):279-87
  3. Ruiz-Irastorza G, Nelson-Piercy C, Khamashta MA. Aspirin to treat obstetric manifestations of the antiphospholipid syndrome. Am J Obstet Gynecol 2001;185(2):523-4
  4. Preston FE, Rosendaal FR, Walker ID, Briët E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6
  5. Lindoff C, Ingermarsson I, Martinsson G. Segelmark M, Thysell H, Astedt B. Preeclampsia is associated with a reduced response to activated protein C. Am J Obstet Gynecol 1997;176(2):457-60
  6. Said JM, Higgins JR, Moses EK, Walker SP, Monagle PT, Brennecke SP. Inherited thrombophilias and adverse pregnancy outcomes: a case-control study in an Australian population. Acta Obstet Gynecol Scand 2012;91(2):250-5
  7. Kelly M, Feroza Dawood, Roy G. Thrombophilia and early pregnancy loss. Best Prac Res Clin Obstet Gynaecol 2012;26(1):91- 102 9. Inherited thrombophilias in pregnancy.Practice Bulletin No.113. American College of Obstetricians and Gynecologist. Obstet Gynecol 2010;116:212-22 10. Silver RM, Zhao Y, Spong CY, Sibai B, Wendel G Jr, Wenstrom K. Prothrombin gene G20210A mutation and obstetric complications. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (NICHD MFMU) Network. Obstet Gynecol 2010;115(1):14-20
  8. Rey E, Kahn SR, David M, Shier I. Trombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361(9361):901-8
  9. Kahn SR, Platt R, McNamara H, Rozen R, Chen MF, Genest J. Inherited thrombophilia and preeclampsia within a multicenter cohort: the Montreal Preeclampsia Study. Am J Obstet Gynecol 2009;200(2):151.e1-9
  10. Alfirevic Z, Roberts D, Martlew V. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101(1):6- 14
  11. Yasuda M, Takakuwa K, Tokunaga A, Tanaka K. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995;86( 4):555-9 15. Howley HE, Walker M